ChartRow logo
ChartRow
Stocks and ETFs
Sign in
GILD
Gilead Sciences Inc.Stock · Healthcare
$131.27+$5.30 (+4.21%)as of market close, Jul 2, 2026
CompareLLYUNHJNJABBVMRKABT

How Gilead Sciences uses its cash

Fiscal year

Where does Gilead Sciences's cash go? This Sankey traces cash from net income through operating cash flow into capex, free cash flow, dividends, buybacks, and debt paydown. Pick any fiscal year. Straight from SEC filings.

Gilead Sciences Inc. · FY2025 · year ended 2025-12-31
Operating cash flow$10.0BNet income$8.5B · 85%D&A$370M · 4%Stock comp$894M · 9%Working capital$245M · 2%Free cash flow$9.5B · 94%Capex$563M · 6%Dividends$4.0B · 40%Buybacks$1.9B · 19%Cash retained$3.5B · 35%

Each fiscal year from SEC filings. Percentages are share of operating cash flow. Sources (net income + non-cash add-backs) flow into operating cash flow, which splits into capex and free cash flow; free cash flow goes to dividends, buybacks, debt paydown, and what's retained. Annual only. For informational purposes only.